Brian Overstreet

Posts by

Health IT

The Non-Negotiable Cost of Drugs

In the past several months the “war on drugs” has intensified. But the war is no longer defined as an offensive against illegal narcotics, but one against pharmaceutical companies and the increasing costs of specialty drugs. With the donkeys, elephants, and other political animals gearing up for the 2016 electoral stampede, it seems that each […]

Health IT

Blame Canada

First, a disclosure. I am Canadian. Well, I’m actually a dual U.S. – Canadian citizen. I was born in Toronto to a U.S. parent and lived there until my family moved to California when I was 15. Among other things, that means that I have two passports and that my kids are also dual citizens. […]

Health IT

A Drug Safety Call to Arms

Last week, the Institute for Safe Medical Practices (ISMP) published an alarming report exposing the dirty secret about drug safety in America. Its report properly chronicled that pharmaceutical companies are largely responsible for collecting and reporting adverse drug events to the Food and Drug Administration (FDA) and most notably, that they’re doing a substandard job at […]

Will 2015 really be the year of healthcare technology?

“21st century businesses will rely on American science, technology, research and development. I want the country that eliminated polio and mapped the human genome to lead a new era of medicine – one that delivers the right treatment at the right time.” – President Barack Obama, State of the Union Address, January 20, 2015.   […]

MedCity Influencers

Did Express Scripts choose the right hepatitis C drug?

Last week’s blog post discussed the dangerous precedent that exclusivity deals between drug manufacturers and payers set. Deals like the one Express Scripts and AbbVie’s signed for discounted rates on the new Hepatitis C drug, Viekira Pak. I argued that these deals emphasize the payer trend of focusing on immediate savings rather than overall outcomes, […]